The Illusion Lite range from Silhouette is extremely lightweight, ensuring maximum wearing comfort. The new model S2967, featured here, is a contemporary classic shape made with SPX and titanium temples and available in six earthy colour combinations. Comes with nose pads to ensure a perfect fit.
Two EI optometrists are progressing through the accreditation programme for performing YAG laser capsulotomies.
Researchers in Australia found successful dry eye disease (DED) treatment with ocular lubricants also diminished migraine severity in susceptible patients.
ProDesign’s latest release continues its legacy of blending Danish design DNA with timeless style, offering eyewear where “every detail is as functional as it is beautiful”, the company said.
The first Eye Institute optometry seminar for 2025 eschewed the usual format of guest lecturers and quickfire presentations of unusual cases in favour of a more relaxed and entertaining wrestling matc
Dual honours for Prof Helen Danesh-Meyer
Elmarie Pretorius is the new national sales manager for Zeiss in New Zealand, while also keeping her Zeiss professional services and product management responsibilities.
JF Rey’s new woman collection, Allure of Metal, is a statement of elegance where colour-intense, delicate metal meets subtle contrasts and unexpected balances. A bold chromatic play, the signature of JF Rey, each design combines two or three tones, carefully juxtaposed and hand applied. The collecti
Building on three years of delivering tailored insurance solutions for optometry, Clarity Insurance Brokers is now expanding OptiSure to include ophthalmology.
US researchers found no significant long-term differences in retinal vascular metrics between patients receiving intravitreal injections (IVI) of anti-VEGF and non-injection control groups.
Highlighting the importance of earlier diagnosis and intervention, a team from the University of Bristol have developed new treatment guidance to help tackle uveitis. “Uveitis is often detect
A strabismus and amblyopia treatment which uses a virtual reality (VR) headset to treat binocular vision has been approved for use in eight- to 12-year-old patients by the US Food and Drug Administrat
